Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insmed

69.18
-4.1500-5.66%
Post-market: 69.320.1400+0.20%17:50 EDT
Volume:3.13M
Turnover:217.39M
Market Cap:12.52B
PE:-12.42
High:72.50
Open:70.43
Low:67.80
Close:73.33
Loading ...

Have Insiders Sold Insmed Shares Recently?

Simply Wall St.
·
09 Feb

Massive Insider Stock Sell-Off at Insmed: What You Need to Know!

TIPRANKS
·
08 Feb

Insmed Is Maintained at Buy by Guggenheim

Dow Jones
·
08 Feb

Insmed's NDA for Lung Disease Drug Gets FDA's Priority Review

Zacks
·
07 Feb

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire
·
07 Feb

Truist Financial Sticks to Their Buy Rating for Insmed (INSM)

TIPRANKS
·
07 Feb

Insmed price target raised to $92 from $83 at JPMorgan

TIPRANKS
·
07 Feb

U.S. RESEARCH ROUNDUP-Altus Power, Amazon, Nevro

Reuters
·
07 Feb

Mizuho Securities Reaffirms Their Buy Rating on Insmed (INSM)

TIPRANKS
·
07 Feb

Insmed Says Brensocatib Application for Lung Disease Gets FDA Priority Review

MT Newswires Live
·
06 Feb

Insmed Gets Speedy FDA Review of Brensocatib for Bronchiectasis

Dow Jones
·
06 Feb

Insmed: FDA accepts NDA for brensocatib

TIPRANKS
·
06 Feb

FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis With Pdufa Target Action Date Set for August 12, 2025

THOMSON REUTERS
·
06 Feb

FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025

PR Newswire
·
06 Feb

Morgan Stanley Raises Price Target on Insmed to $90 From $85, Keeps Overweight Rating

MT Newswires Live
·
06 Feb

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Neurocrine (NBIX) and Stryker (SYK)

TIPRANKS
·
04 Feb

Bank of America Securities Keeps Their Buy Rating on Insmed (INSM)

TIPRANKS
·
04 Feb

Joseph Schwartz’s Buy Rating on Insmed Driven by Promising TPIP Developments in Pulmonary Hypertension Treatment

TIPRANKS
·
04 Feb

TD Cowen Sticks to Its Buy Rating for Insmed (INSM)

TIPRANKS
·
29 Jan

Insmed’s Growth Potential Highlighted by Unmet Needs and Strategic Opportunities

TIPRANKS
·
27 Jan